Kolexia
Orillard Emeline Oncologie médicale
Orillard Emeline
Oncologie médicale
Hôpital Jean-Minjoz
Besançon, France
64 Activités
30 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire à petites cellules Carcinomes Carcinome pulmonaire non à petites cellules Tumeurs du testicule Tumeurs embryonnaires et germinales Tumeurs de la prostate COVID-19 Seconde tumeur primitive

Collaborateurs

Voir plus
Klajer Elodie
Klajer Elodie
Hôpital Jean-Minjoz, Besançon, France
Borg Christophe
Borg Christophe
Hôpital Nord Franche-Comté, Montbéliard, France
Garnier Louis
Garnier Louis
Hôpital Pierre Wertheimer, Bron, France
Lefebvre Loriane
Lefebvre Loriane
Centre Eugène Marquis, Rennes, France

Industries

Voir plus
MSD
3 collaboration(s)
Dernière en 2020
CONGRES COLLOQUES CONVENTIONS
2 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
UCPVax: Anticancer Therapeutic Vaccination Using Telomerase-derives Universal Cancer Peptides in Metastatic Non Small Cell Lung Cancer : A Phase I/II Study
Essai Clinique (Invectys)   13 juillet 2023
The presence of senescent peripheral T-cells is negatively correlated to COVID-19 vaccine-induced immunity in cancer patients under 70 years of age.
Frontiers in immunology   02 juin 2023
210P Anti-CTLA-4 overcomes inhibitory effect of PD1high regulatory T cell on circulating antitumor CD4+ Th1 response in patients treated by anti-PD(L)-1
Abstract Book of the ESMO Immuno-Oncology Congress 2022 7-9 December 2022   01 décembre 2022
LBA6 UCPVax therapeutic vaccination promotes cytotoxic and Th1 polarized antitumor CD4 T cells and epitope spreading in patients with advanced non-small cell lung cancer
Abstract Book of the ESMO Immuno-Oncology Congress 2022 7-9 December 2022   01 décembre 2022
Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.
Essai Clinique (CHU Strasbourg)   18 novembre 2022
Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   07 septembre 2022
Interest of the Addition of Taxanes to Standard Treatment in First-Line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients.
Frontiers in oncology   07 mars 2022
Cabazitaxel activity in men with metastatic castration-resistant prostate cancer with and without DNA damage repair defects.
European journal of cancer (Oxford, England : 1990)   02 novembre 2021
TandHER: Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients
Essai Clinique (CHU Besançon)   04 juin 2021
Valeur pronostique de la lymphopénie T CD4 + dans le cancer du poumon non à petites cellules
25e Congrès de pneumologie de langue française   01 janvier 2021